A No-Show in Politics

Whining and righteousness get you no place in politics. Nevertheless, those are the pop-gun responses of mainstream science to the Bush administration's persistent moves to stack federal science-advisory committees with appointees friendly to its conservative agenda. Here and there, a protesting letter to the editor, a bit of irate testimony on Capitol Hill, preachments to the faithful via an editorial in Science. But when it comes to real politics--raising money and running ads for friendly

Written byDaniel Greenberg
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Whining and righteousness get you no place in politics. Nevertheless, those are the pop-gun responses of mainstream science to the Bush administration's persistent moves to stack federal science-advisory committees with appointees friendly to its conservative agenda. Here and there, a protesting letter to the editor, a bit of irate testimony on Capitol Hill, preachments to the faithful via an editorial in Science. But when it comes to real politics--raising money and running ads for friendly candidates, ringing doorbells, propagandizing the public--science is a no-show on the political landscape, in last November's Congressional elections, as in past elections. Not so lawyers, teachers, physicians, real-estate agents, pharmaceutical drug manufacturers, loan sharks, and polluters. In science and healthcare politics, the administration remains virtually unchallenged, and it's moving aggressively on many fronts.

That means appointees opposed to abortion, family planning, and sex counseling beyond the charming notion of abstinence until marriage in sex-charged America. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies